AstralBio
Boston, US · Founded 2023 · Delaware corporation
Find your way into AstralBio
Sign up to see every warm intro you have to AstralBio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AstralBio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JD
Justin DiMartinoExecutive
PJ
Patrick J. CrutcherExecutive
Reported raises · per SEC filings
Form D private placements$957.4K disclosed across 1 round · 2024
▶$957.4KraisedDec 2024 · 2 investors · BiotechnologyRule 506(b)
▶$957.4KraisedDec 2024 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Justin DiMartinoExecutive Officer, Director
- Patrick J. CrutcherExecutive Officer, Director
- Offering amount
- $957.4K
- Amount sold
- $957.4K
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has AstralBio raised?
- AstralBio has disclosed $957.4K raised across 1 round.
- Where is AstralBio headquartered?
- AstralBio is headquartered in Boston, US.